Follow @TheHPRA
Contact us
Glossary
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
HPRA MIMS Articles May 2020
Notice type:
3rd Party Publications
Date:
13/05/2020
The following articles were provided by the HPRA for inclusion in the May 2020 edition of MIMS Ireland:
Aubagio (teriflunomide) – Risk of new onset of psoriasis and worsening of pre-existing psoriasis
Imfinzi▼(durvalumab) – Risk of myasthenia gravis
« Back
Date Printed: 27/05/2022